Literature DB >> 16458259

A single administration of testosterone reduces fear-potentiated startle in humans.

Erno J Hermans1, Peter Putman, Johanna M Baas, Hans P Koppeschaar, Jack van Honk.   

Abstract

BACKGROUND: Ample evidence from animal research indicates that the gonadal steroid hormone testosterone has fear-reducing properties. Human data on this topic, however, are scarce and far less unequivocal. The present study therefore aimed to scrutinize anxiolytic effects of a single dose of testosterone, using a direct physiological index of fear in humans.
METHODS: Twenty healthy female participants were tested in a double-blind, placebo-controlled crossover design involving sublingual administration of a single dose of testosterone. Four hours after intake, we assessed effects on baseline startle and fear-potentiated startle in a verbal threat-of-shock paradigm.
RESULTS: In accordance with predictions, testosterone administration resulted in reduced fear-potentiated startle, without affecting baseline startle.
CONCLUSIONS: This study provides direct evidence that a single dose of testosterone reduces fear in humans. The relationship of this effect to previous research on anxiolytic effects of benzodiazepines, as well as possible mechanisms of action, is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458259     DOI: 10.1016/j.biopsych.2005.11.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  51 in total

1.  Testosterone reduces the threat premium in competitive resource division.

Authors:  Shawn N Geniole; Valentina Proietti; Brian M Bird; Triana L Ortiz; Pierre L Bonin; Bernard Goldfarb; Neil V Watson; Justin M Carré
Journal:  Proc Biol Sci       Date:  2019-05-29       Impact factor: 5.349

2.  Endogenous steroids and financial risk taking on a London trading floor.

Authors:  J M Coates; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

3.  Genetic and Environmental Contributions to Covariation Between DHEA and Testosterone in Adolescent Twins.

Authors:  Carol A Van Hulle; Mollie N Moore; Elizabeth A Shirtcliff; Kathryn Lemery-Chalfant; H Hill Goldsmith
Journal:  Behav Genet       Date:  2015-01-31       Impact factor: 2.805

4.  Pharmacodynamic response profiles of anxiolytic and sedative drugs.

Authors:  Xia Chen; Freerk Broeyer; Marieke de Kam; Joke Baas; Adam Cohen; Joop van Gerven
Journal:  Br J Clin Pharmacol       Date:  2017-03-17       Impact factor: 4.335

Review 5.  Testosterone and sport: current perspectives.

Authors:  Ruth I Wood; Steven J Stanton
Journal:  Horm Behav       Date:  2011-10-01       Impact factor: 3.587

6.  Endogenous testosterone levels are associated with assessments of unfavourable health information.

Authors:  Stephen L Ristvedt; Robert A Josephs; Scott H Liening
Journal:  Psychol Health       Date:  2012-02-21

Review 7.  Nervous and Endocrine System Dysfunction in Posttraumatic Stress Disorder: An Overview and Consideration of Sex as a Biological Variable.

Authors:  Antonia V Seligowski; Nathaniel G Harnett; Julia B Merker; Kerry J Ressler
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-12-19

8.  In utero cortisol and testosterone exposure and fear reactivity in infancy.

Authors:  Kristin Bergman; Vivette Glover; Pampa Sarkar; Dave H Abbott; Thomas G O'Connor
Journal:  Horm Behav       Date:  2010-01-06       Impact factor: 3.587

9.  Gender differences in financial risk aversion and career choices are affected by testosterone.

Authors:  Paola Sapienza; Luigi Zingales; Dario Maestripieri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

10.  Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Authors:  J M P Baas; N Mol; J L Kenemans; E P Prinssen; I Niklson; C Xia-Chen; F Broeyer; J van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2009-05-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.